12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Deals

Pierre Fabre, Maruho deal

Pierre Fabre granted Maruho exclusive, Japanese rights to develop and commercialize propranolol to treat infantile hemangioma. Maruho will be responsible for regulatory approval...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >